Novel suturelesss scleral IOL fixation technique successful

Article

A novel sutureless scleral IOL fixation technique is successful in patients with insufficient posterior capsule support.

A novel sutureless scleral IOL fixation technique is successful in patients with insufficient posterior capsule support, proves a study in the journal Eye.

Dr Y. Totan et al., Department of Ophthalmology, Fatih University, Medical School, Emek, Turkey, included eight eyes of seven patients in the study. Scleral tunnels were prepared by inserting a 25 G transconjunctival sutureless vitrectomy (TSV) microcannulas using the trocars.

Anterior vitrectomy was completed via the clear corneal paracentesis with an anterior chamber maintainer (ACM). Then the three-piece foldable IOL haptics were incarcerated into the scleral tunnels.

There were no complications recorded such as postoperative endophthalmitis, glaucoma, IOL tilt/decentralization and retinal detachment. There was less incidence of surgical-induced astigmatism because the foldable IOL was injected through a clear corneal incision.

Although the procedure could cause minimal trauma, it also provides good IOL stabilization, a decrease in IOL tilt, shorter operation time and postoperative quiet eye.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.